Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical N-acetyl Cysteine in Mild and Moderate Atopic Dermatitis
NCT07323719Completed
- Sponsor
- Cairo University
- Start
- May 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of acetylcysteine in atopic dermatitis (AD) (2 arms), sponsored by Cairo University. Primary endpoints: Microbial improvement at 4 weeks and Clinical improvement at 4 weeks. Started May 2024; status: completed.
02
Drugs
acetylcysteine
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07323719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07323719.